BAYER 100 mg Pill - white capsule-shape
Generic Name: larotrectinib
Pill with imprint BAYER 100 mg is White, Capsule-shape and has been identified as Vitrakvi 100 mg. It is supplied by Bayer HealthCare Pharmaceuticals Inc.
Vitrakvi is used in the treatment of Solid Tumors and belongs to the drug class multikinase inhibitors. Vitrakvi 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BAYER 100 mg
Vitrakvi
- Generic Name
- larotrectinib
- Imprint
- BAYER 100 mg
- Strength
- 100 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bayer HealthCare Pharmaceuticals Inc.
- National Drug Code (NDC)
- 50419-0391
More about Vitrakvi (larotrectinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.